Economic and epidemiologic aspects of generalized anxiety disorder: a review of the literature

Authors

  • G. Albarracín Consultora Qualiplus 77, S.L.
  • J. Rovira Universidad de Barcelona. Spain
  • L. Carreras Soikos, S.L.
  • J. Rejas Pfizer, S.A

Keywords:

Anxiety disorders, Prevalence, Therapeutics, Cost of illness

Abstract

Introduction. The objective is to assess the prevalence and treatment patterns of generalized anxiety disorder (GAD) in Spain as well as the cost associated to this disorder in different countries.

Methods. A search in the literature of health and economics databases was conducted.

Results. In regards to the 32 references selected, 6 studies had data on the prevalence of GAD and 3 on treatment patterns in Spain and 11 studies on the costs associated to the disease on an international level. The remaining 20 studies were of general interest for methodological or contextual reasons.

Conclusions. GAD is a mental disorder with high prevalence. According to some authors, it is probably underdiagnosed. No appropriate long term treatment is available.

High health care and social costs are associated to GAD. The frequent presence of comorbidity, different definitions and methodologies used in the studies limits the comparability and synthesis of the results. It also makes it difficult to obtain valid estimations of prevalence and costs.

 

Published

2008-05-01

How to Cite

Albarracín, G., et al. “Economic and Epidemiologic Aspects of Generalized Anxiety Disorder: a Review of the Literature”. Actas Españolas De Psiquiatría, vol. 36, no. 3, May 2008, pp. 165-76, https://actaspsiquiatria.es/index.php/actas/article/view/79.

Issue

Section

Review